Articles tagged "Mortality"

2017 American Transplant Congress
The Incidence, Mortality and Prediction Model for Fractures After Kidney Transplantation in the United States.
X. Liu, S. Bae, M. McAdams DeMarco, D. Segev.
JHU, Baltimore, MD
Kidney transplant (KT) recipients are more likely than general population to have fractures. In the general population, fractures are associated with morbidity, mortality, and high…
2017 American Transplant Congress
Trends in Long-Term Outcomes of Kidney Transplantation in Australia and New Zealand.
W. Lim,¹ W.-C. Yeung,² S. Campbell,³ S. Chadban,⁴ P. Clayton,⁵ C. Hawley,³ D. Johnson,³ S. McDonald,⁵ E. Pascoe,⁶ G. Wong,⁷ S. Badve.²
¹Sir Charles Gairdner Hospital, Perth, Australia; ²St George Hospital, Sydney, Australia; ³Princess Alexandra Hospital, Brisbane, Australia; ⁴Royal Prince Alfred Hospital, Sydney, Australia; ⁵University of Adelaide, Adelaide, Australia; ⁶University of Queensland, Brisbane, Australia; ⁷Westmead Hospital, Sydney, Australia
Introduction: Surgical and medical advances have led to considerable improvement in short-term outcomes of kidney transplantation, with 1-year graft and patient survival approaching 100%. However,…
2017 American Transplant Congress
Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.
N. Lam,¹ A. Garg,² G. Knoll,³ J. Kim,⁴ K. Lentine,⁵ E. McArthur,⁶ K. Naylor,⁶ S. Bota,⁶ M. Sood.³
¹University of Alberta, Edmonton, Canada; ²Western University, London, Canada; ³University of Ottawa, Ottawa, Canada; ⁴University of Toronto, Toronto, Canada; ⁵Saint Louis University School of Medicine, St. Louis; ⁶Institute for Clinical Evaluative Sciences, London, Canada
Background: The incidence of venous thromboembolism (VTE) in kidney transplant recipients varies widely in the literature. The implications of VTE for morbidity and mortality in…
2017 American Transplant Congress
Factors in Association with Sepsis Differ Between Simultaneous Pancreas/Kidney and Single Kidney Transplant Recipients.
T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; ³Charite and Max-Delbrück Center, Berlin Institute of Health BIH, Berlin, Germany
As immunosuppressive therapy and allograft survival have improved in simultaneous pancreas/kidney transplant recipients (SPKTRs), the increased incidence of infection has become a major hurdle of…
2017 American Transplant Congress
Pre-Kidney Transplant Lower Extremity Impairment and Post-Transplant Mortality.
A. Nastasi,^1,2 M. McAdams-DeMarco,^1,2 J. Schrack,¹ H. Ying,² C. Haugen,² M. González Fernández,³ D. Segev.^1,2
¹Epidemiology, Johns Hopkins University, Baltimore, MD; ²Surgery, Johns Hopkins University, Baltimore, MD; ³Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, MD
INTRODUCTION. Few objective tests can be easily performed prior to kidney transplantation (KT) to effectively stratify patients by risk of post-KT mortality. The short physical…
2017 American Transplant Congress
Protease Inhibitor-Based Regimens Are Associated with Inferior Outcomes in HIV-Infected Kidney Transplant Recipients.
B. Shelton,¹ D. Sawinski,² R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ J. Locke.¹
¹University of Alabama at Birmingham, Birmingham; ²University of Pennsylvania, Philadelphia
Background: Excellent outcomes have been demonstrated among HIV-infected kidney transplant (KT) recipients when HIV infection is well-controlled. Protease inhibitors (PI) have significant drug-drug interactions with…
2017 American Transplant Congress
Risk Factors for Cryptococcal Disease in Transplant as Compared with Non-Transplant Patients: A Single Center Study.
O. Beaird,¹ O. Garner,² R. Humphries,² J. Schaenman.¹
¹David Geffen School of Medicine at UCLA, Los Angeles, CA; ²UCLA Pathology & Laboratory Medicine, Los Angeles, CA
Purpose: To examine clinical characteristics of non-HIV, immunocompromised patients diagnosed with cryptococcal disease, including solid-organ transplant (SOT) recipients.Methods: We performed retrospective chart review of non-HIV,…
2017 American Transplant Congress
HCV+ Waitlist Candidates More Likely to Die Waiting for Kidney Transplant from HCV- Donor.
B. Shelton,¹ D. Sawinski,² S. Mehta,¹ R. Reed,¹ P. MacLennan,¹ J. Locke.¹
¹University of Alabama at Birmingham, Birmingham; ²University of Pennsylvania, Philadelphia
Background: HCV-infected ESRD patients derive a significant survival benefit from kidney transplantation (KT) over remaining on dialysis. Given the high mortality rates on dialysis and…
2017 American Transplant Congress
Long-Term Outcomes Among Slow versus Delayed or Immediate Graft Function Kidney Transplant Recipients: A Single-Center Experience.
I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Transplant Institute, Henry Ford Health System, Detroit, MI
Purpose: To compare and evaluate short and long-term outcomes for kidney transplant recipients (KTR) with slow graft function (SGF) versus delayed (DGF) or immediate (IGF)…
2017 American Transplant Congress
HCC and Liver Transplantation Following the Recent Allocation Policy Change.
T. Ishaque, A. Massie, M. Bowring, J. Ruck, A. Cameron, B. Philosophe, D. Segev.
Johns Hopkins University, Baltimore
In October 2015, OPTN implemented a revised liver allocation policy to address the disparity between HCC and non-HCC patients in access to deceased-donor liver transplant…